Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Buy
55
STRM Quote, Financials, Valuation and Earnings
Last price:
$3.92
Seasonality move
:
0.29%
Day range:
$3.65 - $3.85
52-week range:
$1.85 - $9.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.78x
P/B ratio:
1.12x
Volume:
11.9K
Avg. volume:
43.9K
1-year change:
-44.55%
Market cap:
$15.6M
Revenue:
$22.6M
EPS (TTM):
-$2.41
Analysts' Opinion
-
Consensus RatingStreamline Health Solutions has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $22.50, Streamline Health Solutions has an estimated downside of -59.02% from its current price of $3.66.
-
Price Target UpsideAccording to analysts, the highest upside price target is $22.50 representing -100% upside increase from its current price of $3.66.
Fair Value
-
According to the consensus of 1 analyst, Streamline Health Solutions has -59.02% downside to fair value with a price target of $22.50 per share.
STRM vs. S&P 500
-
Over the past 5 trading days, Streamline Health Solutions has overperformed the S&P 500 by 12.5% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Streamline Health Solutions does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Streamline Health Solutions revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter Streamline Health Solutions reported revenues of $4.4M.
Earnings Growth
-
Streamline Health Solutions has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Streamline Health Solutions reported earnings per share of -$0.61.
Enterprise value:
27.1M
EV / Invested capital:
1.04x
Price / LTM sales:
0.78x
EV / EBIT:
--
EV / Revenue:
1.46x
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
-8.05x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$9.1M
Return On Assets:
-23.52%
Net Income Margin (TTM):
-50.51%
Return On Equity:
-54.79%
Return On Invested Capital:
-32.78%
Operating Margin:
-44.81%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Income Statement | ||||||
| Revenue | $24.2M | $24M | $18.6M | $6.1M | $4.4M | |
| Gross Profit | $11.1M | $12M | $9.1M | $3.3M | $2M | |
| Operating Income | -$10.9M | -$9.6M | -$7.6M | -$2.2M | -$2M | |
| EBITDA | -$3.7M | -$14.2M | -$3M | -$10.6M | -$676K | |
| Diluted EPS | -$3.01 | -$5.10 | -$2.41 | -$3.15 | -$0.61 | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.5M | $15.2M | $16.8M | $7.7M | $5.4M | |
| Total Assets | $25.3M | $62.4M | $62.2M | $41.1M | $36M | |
| Current Liabilities | $5.8M | $7.4M | $18.6M | $12.7M | $11.9M | |
| Total Liabilities | $7M | $28.8M | $28.1M | $21.4M | $22.1M | |
| Total Equity | $18.4M | $33.6M | $34.2M | $19.8M | $13.9M | |
| Total Debt | $2.3M | $9.9M | $9.8M | $9.8M | $12.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$4.6M | -$4.6M | -$2.7M | -$1.2M | -$1.8M | |
| Cash From Investing | -$2M | -$2.1M | -$679K | -$536K | -$241K | |
| Cash From Financing | $7.9M | -$2.5M | $1.6M | $231K | -$783K | |
| Free Cash Flow | -$6.5M | -$6.7M | -$3.4M | -$1.8M | -$2M | |
STRM
Sector
Market Cap
$15.6M
$48.6M
Price % of 52-Week High
37.55%
47.39%
Dividend Yield
0%
0%
Shareholder Yield
-8.86%
-0.74%
1-Year Price Total Return
-44.55%
-33.25%
Beta (5-Year)
1.552
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$3.56
200-day SMA
Sell
Level
$5.20
Bollinger Bands (100)
Sell
Level
1.86 - 5.98
Chaikin Money Flow
Sell
Level
-93.1M
20-day SMA
Buy
Level
$3.47
Relative Strength Index (RSI14)
Buy
Level
57.44
ADX Line
Buy
Level
20.71
Williams %R
Neutral
Level
-20.9945
50-day SMA
Buy
Level
$2.92
MACD (12, 26)
Buy
Level
0.18
25-day Aroon Oscillator
Buy
Level
16
On Balance Volume
Neutral
Level
134.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.2746)
Sell
CA Score
(Annual)
Level (-1.7168)
Buy
Beneish M-Score
(Annual)
Level (-4.897)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.3509)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
Stock Forecast FAQ
In the current month, STRM has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The STRM average analyst price target in the past 3 months is $22.50.
-
Where Will Streamline Health Solutions Stock Be In 1 Year?
According to analysts, the consensus estimate is that Streamline Health Solutions share price will drop to $22.50 per share over the next 12 months.
-
What Do Analysts Say About Streamline Health Solutions?
Analysts are divided on their view about Streamline Health Solutions share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Streamline Health Solutions is a Sell and believe this share price will rise from its current level to $22.50.
-
What Is Streamline Health Solutions's Price Target?
The price target for Streamline Health Solutions over the next 1-year time period is forecast to be $22.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is STRM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Streamline Health Solutions is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of STRM?
You can purchase shares of Streamline Health Solutions via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Streamline Health Solutions shares.
-
What Is The Streamline Health Solutions Share Price Today?
Streamline Health Solutions was last trading at $3.92 per share. This represents the most recent stock quote for Streamline Health Solutions. Yesterday, Streamline Health Solutions closed at $3.66 per share.
-
How To Buy Streamline Health Solutions Stock Online?
In order to purchase Streamline Health Solutions stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Broadcom vs American Express: Which Is Best?
Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
47
DRUG alert for Jan 3
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Buy
88
BMA alert for Jan 3
Banco Macro SA [BMA] is up 0.88% over the past day.
Sell
50
AGFY alert for Jan 3
Agrify [AGFY] is down 5.86% over the past day.
